U.K. under pressure to reimburse Novartis' Bexsero; Hepatitis B vaccine uptake in China drops;

> The U.K. health secretary is under pressure to add Novartis' ($NVS) Bexsero to the immunization program. Article

> Fears sparked by infant deaths drove a 30% drop in hepatitis B vaccinations in China in December. News

> Australian physicians have warned vaccination rates in some areas have fallen to worrying levels. Piece

> ILiAD Biotechnologies has formed a collaborative alliance to develop live attenuated Bordetella pertussis vaccine technology. Item

> As many as 70 Pakistani health workers have refused to take part in a polio vaccination drive because of security concerns. Post

> Bend Research is to present details of its attempt to create highly stable flu vaccines. Release

> PaxVax has presented interim data from a Phase III trial of its cholera vaccine candidate. News

> Galena Biopharma ($GALE) has partnered with Dr. Reddy's to commercialize its cancer vaccine candidate in India. Article

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.